We are Sorry, This Page doesn't Exist
Bond Report: 10-, 30-year Treasury yields inch up Tuesday as U.S. stocks slide
Long-dated U.S. Treasury rates edge higher Tuesday, with appetite for bonds cooling even amid a round of weaker-than-expected housing data, which undercut the positive tone in equities......»»
Immutep on track to report OS data from AIPAC Phase IIb trial in 2H21
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Over 8 Million Jobs Below Pre-COVID Levels: ADP Employment Data Disappoints In April
Over 8 Million Jobs Below Pre-COVID Levels: ADP Employment Data Disappoints In April After a notable disappointment in the last two months, ADP's National Employment report was expected to print a very positive 850k ad.....»»
BioLine RX rockets on heavy volume after "strikingly positive" trial data on cancer treatment
Shares of BioLine RX Ltd. rocketed 60% toward a 2-year high in very active trading Tuesday, enough to pace all of the premarket gainers, after the biopharmaceutical company announced positive results from a Phase 3 trial of its treatment for multi.....»»
Aptinyx reports "positive" data from Phase 2 study of NYX-783
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Here"s Why Novavax Is Trading Higher Today
Novavax, Inc. (NASDAQ: NVAX) shares are trading higher by 7.3% at $237.68, potentially on continued strength after the company on Friday highlighted the publication of positive Phase 2b malaria vaccine data. read more.....»»
Eli Lilly, Vir Biotechnology, GlaxoSmithKline: Positive data from Phase 2 BLAZE
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Eli Lilly, Vir and Glaxo announce positive data in Phase 2 trial of COVID antibody treatment
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
BrainStorm reports "positive" data in Phase 2 study evaluating NurOwn
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Myovant Sciences, Pfizer report "positive" results from Phase 3 Liberty study
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Aravive expects to report topline data from Phase 1b/2 trial of AVB-500 in 2H21
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Oncorus to report interim data from Phase 1 trial of ONCR-177 in 2H21
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Terns to report data from Phase 2a LIFT study of TERN-101 in 3Q21
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Imara plans to report interim data from Phase 2b IMR-687 trials in 2H21
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Amgen, AstraZeneca report "positive" results from NAVIGATOR Phase 3 trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Alligator Bioscience AB: Year-end Report January-December 2020
STOCKHOLM, Feb. 26, 2021 /PRNewswire/ -- "Safety data has been presented from the ongoing Phase I study with ATOR-1017 in patients with metastatic cancer. The results show a promising safety profile w.....»»
Astellas Pharma reports "positive" results from Phase 3 trials of fezolinetant
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Exelixis announces "positive" final data for Phase 1 cabozantinib trial
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
UniQure"s stock rallies 7% on positive safety data for Huntington"s disease treatment
Shares of UniQure gained 7.2% in trading on Monday after the company said an independent data safety monitoring board said there were no safety concerns in a Phase 2/3 clinical trial for its experimental Huntington's disease treatment. The boar.....»»